1. Unraveling the mysteries of serum albumin—more than just a serum protein
    Angelica M. Merlot et al, 2014, Front. Physiol. CrossRef
  2. Human Serum Albumin and HER2-Binding Affibody Fusion Proteins for Targeted Delivery of Fatty Acid-Modified Molecules and Therapy
    Daoyuan Dong et al, 2016, Mol. Pharmaceutics CrossRef
  3. Review of Neurosurgical Fluorescence Imaging Methodologies
    Brian W Pogue et al, 2010, IEEE J. Select. Topics Quantum Electron. CrossRef
  4. Interaction of Lipoplex with Albumin Enhances Gene Expression in Hepatitis Mice
    Naoki Yoshikawa et al, 2020, Pharmaceutics CrossRef
  5. Efficacy and tolerability of an aminopterin–albumin conjugate in tumor-bearing rats
    Paul Kremer et al, 2002, Anti-Cancer Drugs CrossRef
  6. Antitumor activity of methotrexate-albumin conjugates in rats bearing a Walker-256 carcinoma
    Andreas Wunder et al, 1998, Int. J. Cancer CrossRef
  7. Polymer Therapeutics: Concepts and Applications
    Rainer Haag et al, 2006, Angew. Chem. Int. Ed. CrossRef
  8. Polymere Therapeutika: Konzepte und Anwendungen
    Rainer Haag et al, 2006, Angew. Chem. CrossRef
  9. Phase II study of MTX-HSA in combination with Cisplatin as first line treatment in patients with advanced or metastatic transitional cell carcinoma
    C. Bolling et al, 2006, Invest New Drugs CrossRef
  10. Imaging Tumors with an Albumin-Binding Fab, a Novel Tumor-Targeting Agent
    Mark S. Dennis et al, 2007, Cancer Res CrossRef
  11. Analysis of Immediate Stress Mechanisms upon Injection of Polymeric Micelles and Related Colloidal Drug Carriers: Implications on Drug Targeting
    Tobias Miller et al, 2012, Biomacromolecules CrossRef
  12. Prodrug Strategies in Anticancer Chemotherapy
    Felix Kratz et al, 2008, ChemMedChem CrossRef
  13. Learning from nature: the role of albumin in drug delivery
    Maria J Matos, 2018, Future Medicinal Chemistry CrossRef
  14. Synthesis, pharmacoscintigraphic evaluation and antitumor efficacy of methotrexate-loaded, folate-conjugated, stealth albumin nanoparticles
    Sanyog Jain et al, 2011, Nanomedicine CrossRef
  15. In vitroandin vivoEfficacy of Acid-Sensitive Transferrin and Albumin Doxorubicin Conjugates in a Human Xenograft Panel and in the MDA-MB-435 Mamma Carcinoma Model
    Felix Kratz et al, 2000, Journal of Drug Targeting CrossRef
  16. Octyl syringate is preferentially cytotoxic to cancer cells via lysosomal membrane permeabilization and autophagic flux inhibition
    Minho Won et al, 2021, Cell Biol Toxicol CrossRef
  17. The Role of Extracellular Factors in Human Metastatic Chordoma Cell Growth In Vitro
    Elena Ostroumov et al, 2007, Spine CrossRef
  18. Direct Convective Macromolecule Delivery
    , 1999 CrossRef
  19. Serum Proteins as Drug Carriers of Anticancer Agents: A Review
    Felix Kratz et al, 1998, Drug Delivery CrossRef
  20. A novel D-glyceraldehyde-3-phosphate binding protein, a truncated albumin, with D-glyceraldehyde-3-phosphate dehydrogenase inhibitory property
    Amrita Roy et al, 2009, IUBMB Life CrossRef
  21. null
    F Kratz et al, 2001 CrossRef
  22. Intraoperative Fluorescence Staining of Malignant Brain Tumors Using 5-Aminofluorescein-Labeled Albumin
    Paul Kremer et al, 2009 CrossRef
  23. Native albumin for targeted drug delivery
    Elena Neumann et al, 2010, Expert Opinion on Drug Delivery CrossRef
  24. Harnessing molecular recognition for localized drug delivery
    Renjie Liu et al, 2021, Advanced Drug Delivery Reviews CrossRef
  25. Stability, accumulation and cytotoxicity of an albumin-cisplatin adduct
    Charlotte Møller et al, 2010, Metallomics CrossRef
  26. Combination therapy with the albumin-binding prodrug of doxorubicin (INNO-206) and doxorubicin achieves complete remissions and improves tolerability in an ovarian A2780 xenograft model
    Felix Kratz et al, 2012, Invest New Drugs CrossRef
  27. Coordination conjugates of therapeutic proteins with drug carriers: A new approach for versatile advanced drug delivery
    Zdeněk Kejík et al, 2011, Bioorganic & Medicinal Chemistry Letters CrossRef
  28. Determination of the binding sites for oxaliplatin on insulin using mass spectrometry-based approaches
    Charlotte Møller et al, 2011, Anal Bioanal Chem CrossRef
  29. null
    Felix Kratz et al, 2011 CrossRef
  30. Improving the pharmacokinetic properties of biologics by fusion to an anti-HSA shark VNAR domain
    Mischa R. Müller et al, 2012, mAbs CrossRef
  31. Skin cancer treatment by albumin/5-Fu loaded magnetic nanocomposite spheres in a mouse model
    H. Misak et al, 2013, Journal of Biotechnology CrossRef
  32. Cell-penetrating albumin conjugates for enhanced doxorubicin delivery
    Qianqian Guo et al, 2013, Polym. Chem. CrossRef
  33. null
    Stefan R. Schmidt, 2013 CrossRef
  34. Albumin-based nanocomposite spheres for advanced drug delivery systems
    Heath E. Misak et al, 2014, Biotechnology Journal CrossRef
  35. Albumin-Based Drug Delivery as Novel Therapeutic Approach for Rheumatoid Arthritis
    Andreas Wunder et al, 2003, J Immunol CrossRef
  36. Optimizing the bioavailability of small molecular optical imaging probes by conjugation to an albumin affinity tag
    Anke Hahnenkamp et al, 2014, Journal of Controlled Release CrossRef
  37. Catabolism of 64Cu and Cy5.5-labeled human serum albumin in a tumor xenograft model
    Choong Mo Kang et al, 2016, Amino Acids CrossRef
  38. Curcumin/sunitinib co-loaded BSA-stabilized SPIOs for synergistic combination therapy for breast cancer
    Sunhui Chen et al, 2017, J. Mater. Chem. B CrossRef
  39. Dual-Targeting to Cancer Cells and M2 Macrophages via Biomimetic Delivery of Mannosylated Albumin Nanoparticles for Drug-Resistant Cancer Therapy
    Pengfei Zhao et al, 2017, Adv. Funct. Mater. CrossRef
  40. Synthesis and Biological Evaluation of Homogeneous Thiol-Linked NHC*-Au-Albumin and -Trastuzumab Bioconjugates
    Maria J. Matos et al, 2018, Chem. Eur. J. CrossRef
  41. Endogenous albumin-mediated delivery of redox-responsive paclitaxel-loaded micelles for targeted cancer therapy
    Yujie Zhang et al, 2018, Biomaterials CrossRef
  42. Roles of Albumin-Binding Proteins in Cancer Progression and Biomimetic Targeted Drug Delivery
    Pengfei Zhao et al, 2018, ChemBioChem CrossRef
  43. null
    Shanshan Wang et al, 2019 CrossRef
  44. null
    Xiaopeng Mo et al, 2019 CrossRef
  45. null
    Ramazan Asmatulu et al, 2019 CrossRef
  46. The nanoparticle-facilitated autophagy inhibition of cancer stem cells for improved chemotherapeutic effects on glioblastomas
    Lu Lu et al, 2019, J. Mater. Chem. B CrossRef
  47. Development of a Novel Imaging Agent for Determining Albumin Uptake in Solid Tumors
    S. Daum et al, 2019, Nucl Med Mol Imaging CrossRef
  48. In vivo efficacy of bevacizumab-loaded albumin nanoparticles in the treatment of colorectal cancer
    Inés Luis de Redín et al, 2020, Drug Deliv. and Transl. Res. CrossRef